Abacus Company Equity Multiplier from 2010 to 2024

ABL Stock   7.95  0.03  0.38%   
Abacus Life Company Equity Multiplier yearly trend continues to be quite stable with very little volatility. The value of Company Equity Multiplier is projected to decrease to 1.92. From the period between 2010 and 2024, Abacus Life, Company Equity Multiplier regression line of its data series had standard deviation of  16.60 and standard deviation of  16.60. View All Fundamentals
 
Company Equity Multiplier  
First Reported
2010-12-31
Previous Quarter
2.02417152
Current Value
1.92
Quarterly Volatility
16.60325813
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Abacus Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abacus Life's main balance sheet or income statement drivers, such as Tax Provision of 1.5 M, Interest Income of 624.5 K or Depreciation And Amortization of 3.6 M, as well as many indicators such as Price To Sales Ratio of 16.75, Dividend Yield of 7.0E-4 or PTB Ratio of 3.39. Abacus financial statements analysis is a perfect complement when working with Abacus Life Valuation or Volatility modules.
  
Check out the analysis of Abacus Life Correlation against competitors.
For more information on how to buy Abacus Stock please use our How to buy in Abacus Stock guide.

Latest Abacus Life's Company Equity Multiplier Growth Pattern

Below is the plot of the Company Equity Multiplier of Abacus Life over the last few years. It is Abacus Life's Company Equity Multiplier historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Abacus Life's overall financial position and show how it may be relating to other accounts over time.
Company Equity Multiplier10 Years Trend
Pretty Stable
   Company Equity Multiplier   
       Timeline  

Abacus Company Equity Multiplier Regression Statistics

Arithmetic Mean6.13
Geometric Mean2.34
Coefficient Of Variation270.67
Mean Deviation8.00
Median1.80
Standard Deviation16.60
Sample Variance275.67
Range64.3546
R-Value0.25
Mean Square Error278.08
R-Squared0.06
Significance0.37
Slope0.93
Total Sum of Squares3,859

Abacus Company Equity Multiplier History

2024 1.92
2023 2.02
2022 2.17
2021 66.15

About Abacus Life Financial Statements

Abacus Life investors utilize fundamental indicators, such as Company Equity Multiplier, to predict how Abacus Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Company Equity Multiplier 2.02  1.92 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Abacus Life is a strong investment it is important to analyze Abacus Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Abacus Life's future performance. For an informed investment choice regarding Abacus Stock, refer to the following important reports:
Check out the analysis of Abacus Life Correlation against competitors.
For more information on how to buy Abacus Stock please use our How to buy in Abacus Stock guide.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Insurance Brokers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abacus Life. If investors know Abacus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abacus Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.92)
Earnings Share
(0.22)
Revenue Per Share
1.547
Quarterly Revenue Growth
0.333
Return On Assets
0.0336
The market value of Abacus Life is measured differently than its book value, which is the value of Abacus that is recorded on the company's balance sheet. Investors also form their own opinion of Abacus Life's value that differs from its market value or its book value, called intrinsic value, which is Abacus Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abacus Life's market value can be influenced by many factors that don't directly affect Abacus Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abacus Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Abacus Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abacus Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.